[The clinico-immunological efficacy of the new drug preparation Erbisol in patients with chronic hepatitis].
This report presents results of clinicoimmunological evaluation of 52 patients with chronic hepatites, receiving treatment with <<ERBISOL>>. The data obtained suggest high effectiveness of the preparation in the chronic hepatitis patients not only as a hepatoprotective agent but also as an immunomodulating one exerting effect on both the specific and unspecific links of immunity.
Bychkova
N G
NG
Shipulin
V P
VP
Fomina
A A
AA
Bychkova
S A
SA
D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000917:Antibody Formation / Q000187:drug effects; D001685:Biological Factors / Q000627:therapeutic use*; D004341:Drug Evaluation; D006521:Hepatitis, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects
D000276:Adjuvants, Immunologic; D001685:Biological Factors; C096287:erbisol